Biolase, Inc. (BIOL) Social Stream
BIOLASE INC (BIOL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BIOL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-18 | 1 | $2 | $2 | $2 | $1.21 | 65.29% |
| 2022-03-22 | 1 | $2.001 | $2 | $2 | $1.21 | 65.29% |
| 2022-04-08 | 1 | $50 | $37.5 | $43.75 | $1.21 | 3515.7% |
| 2022-06-03 | 3 | $25 | $10 | $17.5 | $1.21 | 1346.28% |
| 2022-11-18 | 3 | $25 | $5 | $14 | $1.21 | 1057.02% |
| 2023-04-06 | 3 | $12 | $1 | $5 | $1.21 | 313.22% |
| 2023-05-31 | 2 | $2 | $0.4 | $1.133 | $1.21 | -6.36% |
| 2023-06-09 | 2 | $2 | $0.3 | $0.9 | $1.21 | -25.62% |
| 2023-09-08 | 2 | $200 | $30 | $90 | $1.21 | 7338.02% |
| 2023-09-20 | 2 | $40 | $4 | $24.666 | $1.21 | 1938.51% |
| 2023-10-02 | 2 | $40 | $4 | $16.333 | $1.21 | 1249.83% |
| 2023-11-15 | 2 | $40 | $3 | $15.666 | $1.21 | 1194.71% |
| 2023-12-08 | 3 | $40 | $3 | $15.666 | $1.21 | 1194.71% |
The Trend in the Analyst Price Target
Over the past 44 months, BIOL's average price target has gone up $13.29.
BIOL reports an average of 8,320.29% for its upside potential over the past 36 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-06 | 3 | 12 | 1 | 5.000 | 0.28 | 1685.71% |
| 2023-04-06 | 1 | 2 | 1 | 1.500 | 0.28 | 435.71% |
| 2023-10-02 | 2 | 40 | 4 | 16.333 | 1.89 | 764.18% |
| 2023-11-15 | 3 | 40 | 3 | 15.666 | 1.27 | 1133.54% |
| 2023-12-08 | 3 | 40 | 3 | 15.666 | 1.13 | 1286.37% |
BIOL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 26 weeks, BIOL's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how BIOLASE INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 72.74% of that group.
- In terms of how BIOLASE INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1346.83% of that group.
- In the context of Medical Equipment stocks, BIOLASE INC's average analyst price target is greater than 335.02% of them.
- To contextualize these metrics, consider that out of Medical Equipment stocks, BIOLASE INC's upside potential (average analyst target price relative to current price) is greater than 1566.78% of them.
Stocks similar to BIOLASE INC in the Medical Equipment industry regarding analyst recommendations and price targets are RXST, HYPR, and RWLK.
View All Top Stocks by Price Target
Is BIOL a Buy, Hold or Sell? See the POWR Ratings now!